Category: Hematology & Oncology
North America Hematology & Oncology
-
2022-2026 North America Cancer Diagnostics Market Database for the USA, Canada, Mexico - Sales and Market Shares for Reagent and Instrument Suppliers, Major Tumor Markers Volume and Sales Segment Forecasts
... provides information and analysis not available from any other published source , including 2021 supplier shares and 2021-2026 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies ... Read More
-
Bioanalytical Testing Services Market by Type, Application (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User and Region (North America, Europe, APAC, Latin America, MEA) - Global Forecast to 2027
... for the detailed examination of biological and biotechnology products. Bioanalysis enables the quantitative measurement of drugs and their metabolites, biological molecules in unnatural locations or concentrations, DNA, and large molecules. The global bioanalytical testing services ... Read More
-
2022 World Cancer Diagnostics Market: Supplier Shares in US, Europe, and Japan - Competitive Analysis of Leading and Emerging Market Players
... Italy, Japan, Spain, UK, and US. The report analyzes current and emerging suppliers of cancer diagnostics analyzers and reagents, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and ... Read More
-
Herceptin Biosimilar Market, by Indication (Breast Cancer, Gastric Cancer, and Others), by Distribution Channel (Hospital, Oncology Centers, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Sh
... Share, Outlook, and Opportunity Analysis, 2022 - 2028 Trastuzumab, sold under the brand Herceptin, is a monoclonal antibody used for the treatment of breast cancer and gastric cancer. Herceptin is mainly used to treat patients ... Read More
-
Cervical Cancer Diagnostic Tests Market, By Test Type (Pap Smear Test, Colposcopy Test, ECC Test, and HPV Test), By Age Group (Age 20 – 40 and Age Above 40), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - S
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Cervical cancer occurs in the cells of the cervix. Pap smear, colposcopy, and ECC procedures are performed ... Read More
-
DNA/Gene Microarray Market, By Type (oDNA, cDNA), By Application (Genomics, Proteomics, Agricultural biology, Environment, Drug R&D, Gene expression and SNP analysis, Cancer/oncology, Others), and By Region (North America, Latin America, Europe, Asia Paci
... & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 DNA Chips, Biochips or DNA microarrays consists of a microscope slide made materials such as glass, silicon chips, and nylon membrane, which is ... Read More
-
2022-2026 Canada Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
2022-2026 North America Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersUS, Canada, MexicoSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... new 3-country report from LeadingMarketResearch.com . This report is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic testing market, in evaluating emerging ... Read More
-
2022-2026 Mexico Tumor Markers Testing Market High-Growth Opportunities for Cancer Diagnostic Tests and AnalyzersSupplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging ... Read More
-
2022-2026 North America Diagnostics Market Forecasts for 500 Tests in the US, Canada and Mexico - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM - Competitive Strategies, Opportunities for Suppliers
... Diagnostics, TDM - Competitive Strategies, Opportunities for Suppliers This new report from LeadingMarketResearch.com provides granular analysis of the North America diagnostic testing market, including Canada, Mexico, and USA. For each country, the report includes the ... Read More
-
North America Oncology Market Databank
... treatment segment is expected to be the highest contributor to this market, with $138,915.1 Million in 2020, and is anticipated to reach $199,183.8 Million by 2029, registering a CAGR of 4.13%. Cancer diagnostics segment is ... Read More
-
2022-2026 PSA Test Volume and Sales Forecasts: US, Europe, Japan - Hospitals, Commercial Labs, POC Locations
... well as test volume and sales forecasts by country and market segment. Geographic Coverage France, Germany, Italy, Japan, Spain, UK, USA Market Segmentation Centralized Testing Hospitals Commercial/Private Laboratories POC/Decentralized Testing - Physician Offices/Group Practices Cancer ... Read More
-
2022-2026 Papillomavirus Diagnostics Market: USA, Europe, Japan - Supplier Shares, Test Volume and Sales Forecasts by Country and Market Segment - Hospitals, Commercial and Public Health Labs, POC Locations
... sale forecasts for the US, Europe (France, Germany, Italy, Spain, UK) and Japan. The report provides volume and sales forecasts for Papillomavirus tests performed in the following market segments: Hospitals Commercial/Private Labs Physician Offices Public ... Read More
-
North America Next-generation Antibody Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Therapeutic Area (Oncology, and Autoimmune or Inflammatory) and Technology (Antibody-drug conjugates, Bispecific antibodies, Fc engineered antibodies, Antibody fragments & antibody-like proteins, and Biosimilar antibody products)
... proteins, and Biosimilar antibody products) The North America next-generation antibody market is expected to reach US$ 5,428.80 million by 2028 from US$ 2,457.09 million in 2021. It is estimated to grow at a CAGR of ... Read More
-
2022-2026 Succeeding in the Global Hematology and Flow Cytometry Market: US, Europe, Japan - Analyzer and Consumable Supplier Shares, Segment Forecasts by Test and Country, Competitive Intelligence, Emerging Technologies, Latest Instrumentation, Opportunities for Suppliers
... This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report ... Read More
-
2022-2026 Succeeding in the US Hematology and Flow Cytometry Market: Analyzer and Consumable Supplier Shares, Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities for Suppliers
... to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in US hematology and flow cytometry markets during the next five years. The report explores business and technological trends in the ... Read More
-
2022-2026 Succeeding in the US Cancer Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
... emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets,reviews current and emerging tests,analyzes potential applications of various diagnostic technologies,forecasts sales of major tumor ... Read More
-
North America Cervical Cancer Diagnostic Testing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (PAP Testing, HPV Testing, Colposcopy, Cervical Biopsies, Cystoscopy, and Others) and Service Provider (Diagnostics and Research Laboratories, Hospitals and Clinics, Specialty Clinics, and Home Care Services)
... Hospitals and Clinics, Specialty Clinics, and Home Care Services) The North America cervical cancer diagnostic testing market is expected to grow from US$ 2,250.53 million in 2021 to US$ 3,159.09 million by 2028; it is ... Read More
-
Community Oncology Services Global Market Report 2022 Including: 1) By Type: Small Community Oncology Clinics; Medium Community Oncology Clinics; Large Community Oncology Clinics 2) By Cancer Type: Breast Cancer; Lung Cancer; Kidney Cancer; Liver Cancer; Ovarian Cancer; Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer; Others 3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology; Others Covering: Community Care Physicians P.C.; Nebraska Cancer Specialists; US Oncology Inc.(McKesson Corporation); Tufts Medical Center
... focuses on community oncology services market which is experiencing strong growth. The report gives a guide to the community oncology services market which will be shaping and changing our lives over the next ten years ... Read More
-
U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Product Type (Reagents and Kits & Instruments), by Technology (PCR-based (Liquid Biopsy Testing, Tissue Testing) and NGS-based (Liquid Biopsy Testing, Tissue Testing)), by Application, (Genetic Testing, Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028
... Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
-
U.S. Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Surgery, Radiology, Chemotherapy, Immunotherapy), By Animal Type (Canine, Feline), And Segment Forecasts, 2022 - 2030
... expected to expand at a CAGR of 8.7% from 2022 to 2030. The increasing prevalence of cancer in pets, willingness to spend on them by pet owners, and use of canines as a model for ... Read More
-
Mexico In-Vitro Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... government and private hospitals. The prevalence of chronic diseases, like cancer and diabetes, is on the rise, which is further exacerbated by the country's high obesity rates, rising geriatric population, and other lifestyle-related disorders. These ... Read More
-
North America Colorectal Cancer Screening Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... genetic tests, an increase in the prevalence of colorectal cancer, and increasing cancer prevention initiatives. The increasing incidence of colorectal cancer (CRC) is found to be the third most prevalent form of cancer. It accounts ... Read More
-
2022-2026 Mexico Cancer Diagnostics Market Opportunities for Major Tumor Markers - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends in the cancer diagnostics market; reviews current and emerging tests; ... Read More
-
2022-2026 Global Cancer Diagnostics Market Opportunities for Major Tumor Markers: USA, Europe, Japan - Competitive Shares and Growth Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... report is a study of the major business opportunities emerging in the global cancer diagnostics market during the next five years. The report examines trends in the U.S., Europe and Japan; reviews current and emerging ... Read More
Research Assistance
